Structural analysis of the role of Pseudomonas aeruginosa penicillin-binding protein 5 in β-lactam resistance

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 7, 2013, Pages 3137-3146

  Smith, Jeffrey D ^a   Kumarasiri, Malika ^b   Zhang, Weilie ^b   Hesek, Dusan ^b   Lee, Mijoon ^b   Toth, Marta ^b   Vakulenko, Sergei ^b   Fisher, Jed F ^b   Mobashery, Shahriar ^b   Chen, Yu ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEMASE; CARBOXYPEPTIDASE TRANSPEPTIDASE; LYSINE; PENICILLIN BINDING PROTEIN 5; SERINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ESCHERICHIA COLI; IN VITRO STUDY; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CARBOXYPEPTIDASES; CATALYTIC DOMAIN; CRYSTALLOGRAPHY, X-RAY; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MOLECULAR DYNAMICS SIMULATION; PENICILLIN-BINDING PROTEINS; PROTEIN FOLDING; PSEUDOMONAS AERUGINOSA;

EID: 84879018095     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00505-13     Document Type: Article

References (64)

1. Vollmer W, Seligman SJ. 2010. Architecture of peptidoglycan: more data and more models. Trends Microbiol. 18:59-66.
2. Macheboeuf P, Contreras-Martel C, Job V, Dideberg O, Dessen A. 2006. Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes. FEMS Microbiol. Rev. 30:673-691. (Pubitemid 44199345)
3. Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. 2008. The penicillinbinding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol. Rev. 32:234-258. (Pubitemid 351257821)
4. Lovering AL, Safadi SS, Strynadka NCJ. 2012. Structural perspective of peptidoglycan biosynthesis and assembly. Annu. Rev. Biochem. 81:451-478.
5. Yao Z, Kahne D, Kishony R. 2012. Distinct single-cell morphological dynamics under β-lactam antibiotics. Mol. Cell 48:705-712.
6. Bush K. 2010. Alarming β-lactamase-mediated resistance in multidrugresistant Enterobacteriaceae. Curr. Opin. Microbiol. 13:558-564.
7. Bush K, Fisher JF. 2011. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from Gram-negative bacteria. Annu. Rev. Microbiol. 65:455-478.
8. Fisher JF, Mobashery S. 2009. Three decades of the class A β-lactamase acyl-enzyme. Curr. Protein Pept. Sci. 10:401-407.
9. Lister PD, Wolter DJ, Hanson ND. 2009. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22:582-610.
10. Alvarez-Ortega C, Weigand I, Olivares J, Hancock REW, Martínez JL. 2011. The intrinsic resistome of Pseudomonas aeruginosa to β-lactams. Virulence 2:144-146.
11. Breidenstein EBM, de la Fuente-Núñez C, Hancock REW. 2011. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 19: 419-426.
12. Poole K. 2011. Pseudomonas aeruginosa: resistance to the max. Front. Microbiol. 2:65. doi:10.3389/fmicb.2011.00065.
13. Noguchi H, Matsuhashi M, Mitsuhashi S. 1979. Comparative studies of penicillin-binding proteins in Pseudomonas aeruginosa and Escherichia coli. Eur. J. Biochem. 100:41-49. (Pubitemid 10237737)
14. Livermore DM. 1987. Radiolabelling of penicillin-binding proteins (PBPs) in intact Pseudomonas aeruginosa cells: consequences of β-lactamase activity by PBP-5. J. Antimicrob. Chemother. 19:733-742. (Pubitemid 17092058)
15. Moyá B, Beceiro A, Cabot G, Juan C, Zamorano L, Alberti S, Oliver A. 2012. Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities. Antimicrob. Agents Chemother. 56:4771-4778.
16. Noguchi H, Fukasawa M, Komatsu T, Mitsuhashi S, Matsuhashi M. 1985. Mutation in Pseudomonas aeruginosa causing simultaneous defects in penicillin-binding protein 5 and in enzyme activities of penicillin release and D-alanine carboxypeptidase. J. Bacteriol. 162:849-851. (Pubitemid 15059771)
17. Potluri LP, de Pedro MA, Young KD. 2012. Escherichia coli lowmolecular-weight penicillin-binding proteins help orient septal FtsZ, and their absence leads to asymmetric cell division and branching. Mol. Microbiol. 84:203-224.
18. Laubacher ME, Melquist AL, Chandramohan L, Young KD. 2013. Cell sorting enriches Escherichia coli mutants that rely on peptidoglycan endopeptidases to suppress highly aberrant morphologies. J. Bacteriol. 195: 855-866.
19. Massova I, Mobashery S. 1998. Kinship and diversification of bacterial penicillin-binding proteins and β-lactamases. Antimicrob. Agents Chemother. 42:1-17. (Pubitemid 28053319)
20. Sarkar SK, Chowdhury C, Ghosh AS. 2010. Deletion of penicillinbinding protein 5 (PBP5) sensitises Escherichia coli cells to β-lactam agents. Int. J. Antimicrob. Agents 35:244-249.
21. Stefanova ME, Davies C, Nicholas RA, Gutheil WG. 2002. pH, inhibitor, and substrate specificity studies on Escherichia coli penicillin-binding protein 5. Biochim. Biophys. Acta 1597:292-300. (Pubitemid 34607259)
22. Pechenov A, Stefanova ME, Nicholas RA, Peddi S, Gutheil WG. 2003. Potential transition state analogue inhibitors for the penicillin-binding proteins. Biochemistry 42:579-588. (Pubitemid 36105778)
23. Zhang W, Shi Q, Meroueh SO, Vakulenko SB, Mobashery S. 2007. Catalytic mechanism of penicillin-binding protein 5 of Escherichia coli. Biochemistry 46:10113-10121. (Pubitemid 47378603)
24. Davies C, White SW, Nicholas RA. 2001. Crystal structure of a deacylation-defective mutant of penicillin-binding protein 5 at 2.3-Å resolution. J. Biol. Chem. 276:616-623. (Pubitemid 32050861)
25. Nicholas RA, Krings S, Tomberg J, Nicola G, Davies C. 2003. Crystal structure of wild-type penicillin-binding protein 5 from Escherichia coli: implications for deacylation of the acyl-enzyme complex. J. Biol. Chem. 278:52826-52833. (Pubitemid 38035881)
26. Nicola G, Peddi S, Stefanova M, Nicholas RA, Gutheil WG, Davies C. 2005. Crystal structure of Escherichia coli penicillin-binding protein 5 bound to a tripeptide boronic acid inhibitor: a role for Ser-110 in deacylation. Biochemistry 44:8207-8217. (Pubitemid 40799901)
27. Sauvage E, Powell AJ, Heilemann J, Josephine HR, Charlier P, Davies C, Pratt RF. 2008. Crystal structures of complexes of bacterial DDpeptidases with peptidoglycan-mimetic ligands: the substrate specificity puzzle. J. Mol. Biol. 381:383-393.
28. Chen Y, Zhang W, Shi Q, Hesek D, Lee M, Mobashery S, Shoichet BK. 2009. Crystal structures of penicillin-binding protein 6 from Escherichia coli. J. Am. Chem. Soc. 131:14345-14354.
29. Shi Q, Meroueh SO, Fisher JF, Mobashery S. 2008. Investigation of the mechanism of the cell wall DD-carboxypeptidase reaction of penicillinbinding protein 5 of Escherichia coli by QM/MM calculations. J. Am. Chem. Soc. 130:9293-9303. (Pubitemid 352031139)
30. Bobba S, Gutheil WG. 2011. Multivariate geometrical analysis of catalytic residues in the penicillin-binding proteins. Int. J. Biochem. Cell Biol. 43: 1490-1499.
31. Chen Y, Shoichet B, Bonnet R. 2005. Structure, function, and inhibition along the reaction coordinate of CTX-M β-lactamases. J. Am. Chem. Soc. 127:5423-5434. (Pubitemid 40569854)
32. Noguchi H, Fukasawa M, Komatsu T, Iyobe S, Mitsuhashi S. 1980. Isolation of two types of Pseudomonas aeruginosa mutants highly sensitive to a specific group of β-lactam antibiotics and with defect in penicillinbinding proteins. J. Antibiot. (Tokyo) 33:1521-1526. (Pubitemid 11186872)
33. El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B. 2005. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. APMIS 113:187-196. (Pubitemid 40524103)
34. Sykes RB, Nordstrom K. 1972. Microiodometric determination of β-lactamase activity. Antimicrob. Agents Chemother. 1:94-99.
35. Jeon JH, Kim SJ, Lee HS, Cha SS, Lee JH, Yoon SH, Koo BS, Lee CM, Choi SH, Lee SH, Kang SG, Lee JH. 2011. Novel metagenome-derived carboxylesterase that hydrolyzes β-lactam antibiotics. Appl. Environ. Microbiol. 77:7830-7836.
36. Kotsakis SD, Miriagou V, Tzelepi E, Tzouvelekis LS. 2010. Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases. Antimicrob. Agents Chemother. 54:4864-4871.
37. Queenan AM, Shang W, Flamm R, Bush K. 2010. Hydrolysis and inhibition profiles of β-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem. Antimicrob. Agents Chemother. 54:565-569.
38. Otwinowski Z, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326. (Pubitemid 27085611)
39. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. 2007. Phaser crystallographic software. J. Appl. Crystallogr. 40: 658-674. (Pubitemid 47080256)
40. Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, Sali A. 2000. Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 29:291-325. (Pubitemid 30599596)
41. Pieper U, Eswar N, Davis FP, Braberg H, Madhusudhan MS, Rossi A, Marti-Renom M, Karchin R, Webb BM, Eramian D, Shen MY, Kelly L, Melo F, Sali A. 2006. MODBASE: a database of annotated comparative protein structure models and associated resources. Nucleic Acids Res. 34: D291-D295. doi:10.1093/nar/gkj059.
42. Collaborative Computational Project Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50:760-763.
43. Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60:2126-2132. (Pubitemid 41742764)
44. Jones G, Willett P, Glen RC. 1995. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J. Mol. Biol. 245:43-53.
45. Jones G, Willett P, Glen RC, Leach AR, Taylor R. 1997. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 267:727-748. (Pubitemid 27170693)
46. Lee M, Hesek D, Shah IM, Oliver AG, Dworkin J, Mobashery S. 2010. Synthetic peptidoglycan motifs for germination of bacterial spores. Chembiochem 11:2525-2529.
47. Skoog K, Bruzell FS, Ducroux A, Hellberg M, Johansson H, Lehtio J, Hogbom M, Daley DO. 2011. Penicillin-binding protein 5 can form a homo-oligomeric complex in the inner membrane of Escherichia coli. Protein Sci. 20:1520-1529.
48. Folkesson A, Jelsbak L, Yang L, Johansen HK, Ciofu O, Høiby N, Molin S. 2012. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat. Rev. Microbiol. 10:841-851.
49. Page MGP, Heim J. 2009. Prospects for the next anti-Pseudomonas drug. Curr. Opin. Pharmacol. 9:558-565.
50. Bonomo RA. 2011. The clinical problem of β-lactam resistance in MDR Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa, p 383-399. In J-M Frère (ed), β-Lactamases. Nova Science, New York, NY.
51. Pratt RF, McLeish MJ. 2010. Structural relationship between the active sites of β-lactam-recognizing and amidase signature enzymes: convergent evolution? Biochemistry 49:9688-9697.
52. Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. 2011. Carbapenems: past, present, and future. Antimicrob. Agents Chemother. 55:4943-4960.
53. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. 2012. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin. Microbiol. Rev. 25:682-707.
54. Perez F, Endimiani A, Hujer KM, Bonomo RA. 2007. The continuing challenge of ESBLs. Curr. Opin. Pharmacol. 7:459-469. (Pubitemid 47560222)
55. Patel G, Bonomo RA. 2011. Status report on carbapenemases: challenges and prospects. Expert Rev. Anti Infect. Ther. 9:555-570.
56. Maveyraud L, Mourey L, Kotra LP, Pedelacq J-D, Guillet V, Mobashery S, Samana JP. 1998. Structural basis for clinical longevity of carbapenem antibiotics in the face of challenge by the common class A β-lactamases from the antibiotic-resistant bacteria. J. Am. Chem. Soc. 120:9748-9752. (Pubitemid 28462478)
57. Nukaga M, Bethel CR, Thomson JM, Hujer AM, Distler A, Anderson VE, Knox JR, Bonomo RA. 2008. Inhibition of class A β-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1. J. Am. Chem. Soc. 130:12656-12662.
58. Fonseca F, Chudyk EI, van der Kamp MW, Correia A, Mulholland AJ, Spencer J. 2012. The basis for carbapenem hydrolysis by class A β-lactamases: a combined investigation using crystallography and simulations. J. Am. Chem. Soc. 134:18275-18285.
59. Petrella S, Ziental-Gelus N, Mayer C, Renard M, Jarlier V, Sougakoff W. 2008. Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A β-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France. Antimicrob. Agents Chemother. 52:3725-3736.
60. Kotsakis SD, Caselli E, Tzouvelekis LS, Petinaki E, Prati F, Miriagou V. 2013. Interactions of oximino-substituted boronic acids and β-lactams with the CMY-2-derived extended-spectrum cephalosporinases CMY-30 and CMY-42. Antimicrob. Agents Chemother. 57:968-976.
61. Nicola G, Tomberg J, Pratt RF, Nicholas RA, Davies C. 2010. Crystal structures of covalent complexes of β-lactam antibiotics with Escherichia coli penicillin-binding protein 5: toward an understanding of antibiotic specificity. Biochemistry 49:8094-8104.
62. Taibi P, Mobashery S. 1995. Mechanism of turnover of imipenem by the TEM β-lactamase revisited. J. Am. Chem. Soc. 117:7600-7605.
63. Dzhekieva L, Rocaboy M, Kerff F, Charlier P, Sauvage E, Pratt RF. 2010. Crystal structure of a complex between the Actinomadura R39 DDpeptidase and a peptidoglycan-mimetic boronate inhibitor: interpretation of a transition state analogue in terms of catalytic mechanism. Biochemistry 49:6411-6419.
64. Papp-Wallace KM, Senkfor B, Gatta J, Chai W, Taracila MA, Shanmugasundaram V, Han S, Zaniewski RP, Lacey BM, Tomaras AP, Skalweit MJ, Harris ME, Rice LB, Buynak JD, Bonomo RA. 2012. Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3. Antimicrob. Agents Chemother. 56:5687-5692.